PDGF and FGF receptors in health and disease

Growth Factors and Cytokines in Health and Disease

Volumn 1, Issue C, 1996, Pages 179-228

  Fantl, Wendy J ^a   Williams, Lewis T ^a   Peters, Kevin G ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0343241552     PISSN: 18745687     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5687(96)80009-7     Document Type: Review

References (352)

1. Adams J.M., Houston H., Allen J., Lints T., and Harvey R. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene 7 (1992) 611-618
2. Adnane J., Gaudray P., Dionne C.A., Crumley G., Jaye M., Schlessinger J., Jeanteur P., Birnbaum D., and Theillet C. TEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 6 (1991) 659-663
3. Aitkin A. 14-3-3 proteins on the map. TIBS 20 (1995) 95-96
4. Amaya E., Musci T.J., and Kirschner. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell 66 (1991) 257-270
5. Amaya E., Stein P.A., Musci T.J., and Kirschner M.W. FGF signaling in the early specification of mesoderm in Xenopus. Development 118 (1993) 477-487
6. Anderson K.J., Dam D., Lee S., and Corman C.W. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature 332 (1988) 360-361
7. Anderson R., Landry M., and Muneoka K. Maintenance of ZPA signaling in cultured mouse limb bud cells. Development 117 (1993) 1421-1433
8. Antonaides H.N., Galanopoulos T., Neville-Golden J., and O'Hara C.J. Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products. Proc. Natl. Acad. Sci. USA 89 (1992) 3942-3946
9. Aronheim A., Engelberg D., Li N., Al-Alawi N., Schlessinger J., and Karin M. Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell 78 (1994) 949-961
10. Asai T., Wanaka A., Kato H., Masana Y., Seo M., and Tohyama M. Differential expression of two members of FGF receptor gene family, FGFR-1 and FGFR-2, in the adult rat central nervous system. Mol. Brain Res. 17 (1993) 174-178
11. Avivi A., Yayon A., and Givol D. A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain 111. FEBS Lett. 330 (1993) 249-252
12. Avruch J., Zhang X.-f., and Kyriakis J.M. Raf meets Ras: Completing the framework of a signal transduction pathway. TIBS 19 (1994) 279-283
13. Backer J.M., Myers M.G., Shoelson S.E., Chin D.J., Sun X.J., Miralpeix M., Hu P., Margolis B., Skolnik Y., Schlessinger J., and White M.F. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO 11 (1992) 3469-3479
14. Barres B.A., Hart I.K., Coles H.S., Burne J.F., Voyvodic J.T., Richardson W.D., and Raff M.C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70 (1992) 31-46
15. Barres B.A., and Raff M.C. Control of oligodendrocyte number in the developing rat optic nerve. Neuron 12 (1994) 935-942
16. Barres B.A., Schmid R., Sendnter M., and Raff M.C. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118 (1993) 283-295
17. Battegay E.J., Rupp J., Iruela-Arispe L., Sage E.H., and Pech M. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF β-receptors. J. Cell Biol. 125 (1994) 917-928
18. Beitz J.G., Davol P., Calrk J.W., Kato J., Medina M., Frackelton A.R., Lappi D.A., Baird A., and Calabresi P. Antitumor activity of basic fibroblast growth factor-sapporin mitotoxin in vitro and in vivo. Cancer Res. 52 (1992) 227-230
19. Bejeek B., Li D., and Deuel T. Transformation by v-sis occurs by an internal autoactivation mechanism. Science 245 (1989) 1469-1498
20. Bell L., and Madri J.A. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ. Res. 65 (1989) 1057-1065
21. Bellus G.A., McIntosh I., Smith E.A., Aylsworth A.S., Kaitila I., Horton W.A., Greenhaw G.A., Hecht J.T., and Francomano C.A. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nature Genetics 10 (1995) 357-359
22. Bennett A.M., Tang T.L., Sugimoto S., Walsh C.T., and Neel B.G. Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor β to Ras. Proc. Natl. Acad. Sci. USA 91 (1994) 7335-7339
23. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 361 (1993) 315-325
24. Bilder G.E., Krawiec J.A., McVety K., Gazit A., Gilon C., Lyall R., Zilberstein A., Levitzki A., Perrone M.H., and Schreiber A.B. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells. Am. J. Physiol. 260 (1991) C721-C730
25. Biro S., Siegall C.B., Fu Y.-M., Speir E., Pastan I., and Epstein S.E. In vitro effects of a recombinant toxin targeted to the fibroblast growth factor receptor on rat vascular smooth muscle and endothelial cells. Circ. Res. 71 (1992) 640-645
26. Blaikie P., Immanuel D., Wu J., Li N., Yajnik V., and Margolis B. A Region in Shc Distinct from the SH2 Domain Can Bind Tyrosine-phosphorylated Growth Factor Receptors. Biol. Chem. 269 No. 51 (1994) 32031-32034
27. Boguski M.S., and McCormick F. Proteins regulating Ras and its relatives. Nature 366 (1993) 643-654
28. Bollag G., and McCormick F. Regulators and effectors of ras proteins. Ann. Rev. Cell Biol. 7 (1991) 601-632
29. Bonfini L., Karlovich C.A., Dasgupta C., and Banerjee U. The son of sevenless gene product: A putative activator of Ras. Science 255 (1992) 603-606
30. Booker G.W., Gout I., Downing A.K., Driscoll P.C., Boyd J., Waterfield M.D., and Campbell I.D. Solution structure and ligand-binding site of the SH3 domain of the p85a subunit of phosphatidylinositol 3-kinase. Cell 73 (1993) 813-822
31. Bork P., and Margolis B. A Phosphotyrosine Interaction Domain. Cell 80 (1995) 693-694
32. Bourne H.R., Sanders D.A., and McCormick F. The GTPase superfamily: Conserved structure and molecular mechanism. Nature 349 (1991) 117-127
33. Bowtell D., Fu P., Simon M., and Senior P. Identification of murine homologues of the Drosophila son of sevenless gene: Potential activators of ras. Proc. Natl. Acad. Sci. USA 89 (1992) 6511-6515
34. Brogi E., Winkles J.A., Underwood R., Clinton S.K., Alberts G.F., and Libby P. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries-Association of acidic FGF with plaque microvessels and macrophages. J. Clin. Invest. 92 (1993) 2408-2418
35. Bruder J.T., Heidecker G., and Rapp U.R. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes & Development 6 (1992) 545-556
36. Buday L., and Downward J. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grg2 adapter protein, and sos nucleotide exchange factor. Cell 73 (1993) 611-620
37. Burgering B.M.T., and Bos J. Regulation of Ras-mediated signalling: More than one way to skin a cat. Tibs 20 (1995) 18-22
38. Burgering B.M.T., and Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376 (1995) 599
39. Cai H., Erhardt P., Troppmair J., Diaz-Meco M.T., Sithanandam G., Rapp U.R., Moscat J., and Cooper G.M. Hydrolysis of phosphatidylcholine couples ras to activation of raf protein kinase during mitogenic signal transduction. Mol. Cell. Biol. 13 12 (1993) 7645-7651
40. Cano E., and Mahadevan L.C. Parallel signal processing among mammalian MAPKs. TIBS 20 (1995) 117-122
41. Carpenter C.L., Auger K.R., Chanudhuri M., Yoakim M., Schaffhausen B., Shoelson S., and Cantley L.C. Phosphoinositide 3-Kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit. J. Biol. Chem 268 (1993) 9478-9483
42. Casscells W. Migration of smooth muscle and endothelial cells-Critical events in restenosis. Circulation 86 (1992) 723-729
43. Chardin P., Camonis J.H., Gale N.W., Van Aelst L., Schlessinger J., Wigler M., and Bar-Sagi D. Science 260 (1993) 1338-1343
44. Chaudhry A., Papanicolaou V., Oberg K., Helin C.H., and Funa K. Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system. Cancer Res. 52 (1992) 1006-1012
45. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Blenis J., and Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14 7 (1994) 4902-4911
46. Chellaiah A.T., McEwen D.G., Werner S., Xu J., and Ornitz D.M. Fibroblast growth factor receptor (FGFR) 3. Biol. Chem. 269 (1994) 11620-11627
47. Chen J.K., Lane W.S., Brauer A.W., Tanaka A., and S.L. S. Biased combinatorial libraries: Novel ligands for the SH3 domain of phosphatidylinositol 3-kinase. Am. Chem. Soc. 115 (1993) 12591-12592
48. Chen R.-H., Tung R., Abate C., and Blenis J. Cytoplasmic to nuclear signal transduction by mitogen-activated protein kinase and 90 kDa ribosomal S6 kinase. Biochemical Society Transactions 21 (1993) 895-900
49. Cheon H.-G., LaRochelle W.J., Bottora D.P., Burgess W.H., and Aaronson S.A. High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains. Proc. Natl. Acad. Sci. USA 91 (1994) 989-993
50. Chung C.K., and Antoniades H.N. Expression of c-sis/platelet-derived growth factor B, insulin-like growth factor I, and transforming growth factor α messenger RNAs and their respective receptor messenger RNAs in primary human gastric carcinomas: In vivo studies with in situ hybridization and immunocytochemistry. Cancer Res. 52 (1992) 3453-3459
51. s6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370 (1994) 71-75
52. Clark S.G., Stern M.J., and Horvitz H.R. C. elegans cell-signaling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature 356 (1992) 340-344
53. Claude P., Parada I.M., Gordon K.A., D'Amore P.A., and Wagner J.A. Acidic fibroblast growth factor stimulates adrenal chromaffin cells to proliferate and to extend neurites, but is not a long-term survival factor. Neuron 1 (1988) 783-790
54. Cohn M.J. Fibroblast growth factors induce additional limb development from the flank of chick embryos. Cell 80 (1995) 739-746
55. Collarini E.J., Pringle N., Mudhar H., Stevens G., Kuhn R., Monuki E.S., Lemke G., and Richardson W.D. Growth factors and transcription factors in oligodendrocyte development. J. Cell Science 15 (1991) 117-123
56. Cornell R., and Kimelman D. Activin-mediated mesoderm induction requires FGF. Development 120 (1994) 435-462
57. Coughlin S.R., Escobedo J.A., and Williams L.T. Role of phosphatidyl-inositol kinase in PDGF receptor signal transduction. Science 243 (1989) 1191-1194
58. Courtneidge S.A., Kypta R.M., Cooper J.A., and Kazlauskas A. Platelet-derived growth factor receptor sequences important for binding of src family tyrosine kinases. Cell Growth Differ. 2 (1991) 483-486
59. Cowley S., Paterson H., Kemp P., and Marshall C.J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77 (1994) 841-852
60. Cuevas P., Gonzalez A.M., Carceller F., and Baird A. Vascular response to basic fibroblast growth factor when infused onto the normal adventitia or into the injured media of the rat carotid artery. Circ. Res. 69 (1991) 360-369
61. D'Arcangelo G., and Halegoua S. A branched signaling pathway for nerve growth factor is revealed by Src-, Ras, and Raf-mediated gene inductions. Mol. Cell. Biol. 13 (1993) 3146-3155
62. Daum G., Eisenmann-Tappe I., Fries H.-W., Troppmair J., and Rapp U.R. The ins and outs of Raf kinases. Tibs 19 (1994) 474-480
63. Davis R.J. MAPKs: New JNK expands the group. Tibs 19 (1994) 470-473
64. de Groot R.P., Ballou L.M., and Sassone-Corsi P. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: An alternative route to mitogen-induced gene expression. Cell 79 (1994) 81-91
65. DeHamer M.K., Guevara J.L., Hannon K., Olwin B.B., and Calof A.L. Genesis of olfactory receptor neurons in vitro: Regulation of progenitor cell divisions by fibroblast growth factors. Neuron 13 (1994) 1083-1097
66. Deng C.-X., Wynshaw-Boris A., Shen M.M., Daugherty C., Ornitz D.M., and Leder P. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes & Development 8 (1994) 3045-3057
67. der Hertog J., Tracy S., and Hunter T. Phosphorylation of receptor protein-tyrosine phosphatase α on Tyr 789, a binding site for the SH3-SH2-SH3 adaptor protein GRB2 in vivo. EMBO J. 13 (1994) 3020-3032
68. Derijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M., and Davis R.J. JNK1: A protein kinase stimulated by UV light and ha-ras that binds and phosphorylates the c-Jun activation domain. Cell 76 (1994) 1025-1037
69. Derijard B., Raingeaud J., Barrett T., Wu I.-H., Han J., Ulevitch R.J., and Davis R.J. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267 (1995) 682-685
70. Deuel T., Pierce G., Yeh H., Shawver L., Milner P., and Kumura A. PDGF/sis in normal and neoplastic cell growth. J. Cell. Phys. 5 (1987) 95-99
71. Dickson B., Sprenger F., Morrison D., and Hafen E. Raf functions downstream of Ras1 in the sevenless signal transduction pathway. Nature 360 (1992) 600-603
72. DiMario J., Buffinger N., Yamada S., and Strohman R.C. Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle. Science 244 (1989) 688-690
73. DiMario J., and Strohman R.C. Satellite cells from dystrophic (mdx) mouse muscle are stimulated by fibroblast growth factor in vitro. Differentiation 39 (1988) 42-49
74. Downward J. The GRB2/Sem-5 adaptor protein. FEBS Letters 338 (1994) 113-117
75. Downward J. Regulating s6 kinase. Nature 371 (1994) 378-379
76. Duan D.-S.R., Pazin M.J., Fretto L.J., and Williams L.T. A functional soluble extracellular region of the platelet-derived growth factor (PDGF) β- receptor antagonizes PDGF-stimulated responses. J. Biol. Chem. 266 (1991) 413-418
77. Duan D.-S.R., Werner S., and Williams L.T. A naturally occurring secreted form of fibroblast growth factor (FGF) receptor 1 binds basic FGF in preference over acidic FGF. J. Biol. Chem. 267 (1992) 16076-16080
78. lck. Nature 362 (1993) 87-89
79. Egan S.E., Giddings B.W., Brooks M.W., Buday L., Sizeland A.M., and Weinberg R.A. Association of sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363 (1993) 45-51
80. Engelmann G.L., Dionne C.A., and Jaye M.C. Acidic fibroblast growth factor and heart development-role in myocyte proliferation and capillary angiogenesis. Circ. Res. 72 (1993) 7-19
81. Escobedo J.A., Kaplan D.R., Kavanaugh W.M., Turck C.W., and Williams L.T. A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. Mol. Cell. Biol. 11 (1991) 1125-1132
82. Escobedo J.A., Navankasattusas S., Kavanaugh W.M., Milfay D., Fried V.A., and Williams L.T. cDNA cloning of a novel 85kd protein that has SH2 domains and regulates binding of Pi3-kinase to the PDGF beta-receptor. Cell 65 (1991) 75-82
83. Escobedo J.A., and Williams L.T. A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF. Nature (London) 335 (1988) 85-87
84. Fallon J.F. FGF-2 apical ectodermal ridge growth signal for chick limb development. Science 264 (1994) 104-107
85. Submitted. Fantl W.J., Cramer L.P., Klippel A., Garcia P.D., Mitchison T.J., and Williams L.T. P13-kinase and rac1 are on the same pathway that regulates lamellipodia formation in fibroblasts (1995)
86. Fantl W.J., Escobedo J.A., Martin G.A., Turck C.W., del Rosario M., McCormick F., and Williams L.T. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69 (1992) 413-423
87. Fantl W.J., Johnson D.E., and Williams L.T. Signaling by receptor tyrosine kinases. Ann. Rev. Biochem. 62 (1993) 453-481
88. Fantl W.J., Muslin A.J., Martin J.A., MacNicol A.M., Gross R.W., and Williams L.T. Activation of Raf-1 with 14-3-3 proteins. Nature 371 (1994) 612-614
89. Feng G.-S., and Pawson T. Phosphotyrosine phosphatases with SH2 domains: Regulators of signal transduction. TIG 10 (1994) 54-58
90. Ferns G.A., Raines E.W., Sprugel K.H., Montani A.S., Reidy M.A., and Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody of PDGF. Science 253 (1991) 1129-1132
91. Finney R.E., Robbins S.M., and Bishop J.M. Association of pRas and pRaf-1 in a complex correlates with activation of a signal transduction pathway. Current Biology 3 (1993) 805-812
92. Folkman J., and Klagsbrun M. Angiogenic factors. Science 235 (1987) 442-447
93. Forough R., Xi Z., MacPhee M., Friedman S., Engleka K.A., Sayers T., Wiltrout R.H., and Maciag T. Differential transforming abilities of non-secreted and secreted forms of human fibroblast growth factor-1. J. Biol. Chem. 268 (1993) 2960-2968
94. Forsberg K., Valyi-Nagy I., Heldin C.H., Herlyn M., and Westermark B. Platelet-derived growth factor (PDGF) in oncogenesis: Development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc. Natl. Acad. Sci USA 90 (1993) 393-397
95. Freed E., Symons M., Macdonald S.G., McCormick F., and Ruggieri R. Binding of 14-3-3 proteins to the protein kinase raf and effects on its activation. Science 265 (1994) 1713-1716
96. Fu H., Xia K., Pallas D.C., Cui C., Conroy K., Narsimhan R.P., Mamon H., Collier R.J., and Roberts T.M. Interaction of the protein kinase Raf-1 with 14-3-3 Proteins. Science 266 (1994) 126-129
97. Garrett J.S., et al. Proc. Natl. Acad. Sci. USA 81 (1984) 7466
98. Gibbs J.B., Oliff A., and Kohl N.E. Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. (Review). Cell 77 (1994) 175-178
99. Gille H., Sharrocks A.D., and Shaw P. Phosphorylation of p62TCF by MAP kinase stimulates complex formation at c-fos promoter. Nature 358 (1992) 414-417
100. Glazer L., and Shilo B.-Z. The Drosophila FGF-R homolog is expressed in the embryonic tracheal system and appears to be required for directed tracheal cell extension. Genes & Development 5 (1991) 697-705
101. Golub T.R., Barker G.F., Lovett M., and Gilliland G. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77 (1994) 307-316
102. Green J.B.A., New H.V., and Smith J.C. Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distance axes of the mesoderm. Cell 71 (1992) 731-739
103. Guha A. Platelet-derived growth factor: A general review with emphasis on astrocytomas. Ped. Neurosurgery 17 (1991) 14-20
104. Guimond S., Maccarana M., Olwin B.B., Lindahl U., and Rapraeger A.C. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distance requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem. 268 (1993) 1993
105. Gustafson T.A., He W., and Craparo A. Phosphotyrosine-dependent interaction of SHC and IRS-1 with the NPEY motif of the insulin receptor via a novel (non-SH2) domain. Mol. Cell. Biol. 15 (1995) 2500-2508
106. Hafner S., Adler H.S., Mischak H., Janosch P., Heidecker G., Wolfman A., Pippig S., Lohse M., Ueffing M., and Kolch W. Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14 (1994) 6696-6703
107. Hall A. Ras-related GTPases and the cytoskeleton. Mol. Biol. of the Cell 3 (1992) 475-479
108. Hallberg B., Rayter S.I., and Downward J. Interaction of ras and raf in intact mammalian cells upon extracellular stimulation. Biol. Chem. 269 6 (1993) 3913-3916
109. Hanks S.K., and Quinn A.M. Protein kinase catalytic domain sequence database: Identification of conserved features of primary structure and classification of family members. Meth. Enzymol. 200 (1991) 38-62
110. Hattori Y., Odagiri H., Katoh O., Sakamoto H., Morita T., Shimotohno K., Tobinai K., Sugimura T., and Terada M. K-sam-related gene, N-sam, encodes fibroblast growth factor receptor and is expressed in t-lymphocytic tumors. Cancer Res. 52 (1992) 3367-3371
111. Hattori Y., Odagiri H., Nakatani H., Miyagawa K., Naito K., Sakamoto H., Katoh O., Yoshida T., Sugimura T., and Terada M. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc. Natl. Acad. Sci. USA 87 (1990) 5983-5987
112. Heldin C.-H. Structural and functional studies on platelet-derived growth factor. EMBO 11 12 (1992) 4251-4259
113. Heldin C.-H. Dimerization of cell surface receptors in signal transduction. Cell 80 (1995) 213-223
114. Heldin C.-H., and Westermark B. Platelet-derived growth factor: mechanism of action and possible in vivo function. Cell Regulation 1 (1990) 555-566
115. Henriksen R., Funa K., Wilander E., Backstrom T., Ridderheim M., and Oberg K. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res. 53 (1993) 4550-4554
116. Hermanson M., Funa K., Hartman M., Claesson-Welsh L., Heldin C.H., Westermark B., and Nister M. Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Research 52 (1992) 3213-3219
117. Hill C.S., and Treisman R. Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80 (1995) 199-211
118. Hofer F., Fields S., Schneider C., and Martin G.S. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc. Natl. Acad. Sci. USA 91 (1994) 11089-11093
119. Holmgren L., Glaser A., Pfeifer-Ohlsson S., and Ohlsson R. Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. Development 113 (1991) 749-754
120. Hu P., Mondino A., Skolnick E.Y., and Schlessinger J. Cloning of a novel, ubiquitously expressed human phosphatidyl 3-kinase and identification of its binding site on p85. Mol. Cell. Biol. 13 (1993) 7677-7688
121. (In press). Hu Q., Klippel A., Muslin A.J., Fantl W.J., and Williams L.T. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science (1995)
122. Hu Q., Milfay D., and Williams L.T. Binding of NCK to SOS and activation of Ras-dependent gene expression. Mol. Cell. Biol. 15 (1995) 1169-1174
123. Hughes D.A., Ashworth A., and Marshall C.J. Complementation of byr1 in fission yeast by mammalian MAP kinase requires coexpression of Raf kinase. Nature 364 (1993) 349-352
124. Iida S., Katoh O., Tokunaga A., and Terada M. Expression of fibroblast growth factor gene family and its receptor gene family in the human upper gastrointestinal tract. Biochem. Biophys. Res. Comm. 199 (1994) 1113-1119
125. Ip N.Y., Boulton T.G., Li Y., Verdi J.M., Birren S.J., Anderson D.J., and Yancopoulos G.D. CNTF, FGF, and NGF collaborate to drive the terminal differentiation of MAH cells in postmitotic neurons. Neuron 13 (1994) 443-455
126. Jabs E.W., Li X., Scott A.F., Meyers G., Chen W., Eccles M., Mao J., Charnas L.R., Jackson C.E., and Jaye M. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nature Genetics 8 (1994) 275-279
127. James G.L., Goldstein J.L., Brown M.S., Rawson T.E.,T.C., S., McDowell R.S., Crowley C.W., Lucas B.K., Levinson A.D., and Marsters Jr. J.C. Benzodiazepine peptidomimetics: Potent inhibitors of Ras farnesylation in animal cells. Science 260 (1993) 1877-1878
128. Jawien A., Bowen-Pope D.F., Lindner V., Schwartz S.M., and Clowes A.W. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89 (1992) 507-511
129. Jefferies H.B.J., Reinhard C., Kozma S.C., and Thomas G. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc. Natl. Acad. Sci. USA 91 (1994) 4441-4445
130. Jessell T.M., and Melton D.A. Diffusible factors in vertebrate embryonic induction. Cell 68 (1992) 257-270
131. Johnson D.E., and Williams L.T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60 (1993) 1-41
132. Joly M., Kazlauskas A., Fay F.S., and Corvera S. Disruption of the PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science 263 (1994) 682-687
133. Kamohara S., Hayashi H., Todaka M., Kanai F., Ishii K., Imanaka T., Escobedo J.A., Williams L.T., and Ebina Y. Platelet-derived growth factor triggers translocation of the insulin-regulatable glucose transporter (type 4) predominantly through phosphatidylinositol 3-kinase binding sites on the receptor. Biochemistry 92 (1995) 1077-1081
134. Kan M., Wang F., Xu J., Crabb J.W., Hou J., and McKeehan W.L. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259 (1993) 1918-1921
135. Kao K.R., and Elinson R.P. The entire mesodermal mantle behaves as Spemann's organizer in dorsoanterior enhanced Xenopus laevis embryos. Dev. Biol. 127 (1988) 64-77
136. Kao K.R., and Elinson R.P. Dorsalization of mesoderm induction by lithium. Dev. Biol. 132 (1989) 81-90
137. Kapeller R., and Cantley L.C. Phosphatidylinositol 3-Kinase. BioEssays 16 8 (1994) 565-575
138. Kapeller R., Chakrabarti R., Cantley L., Fay F., and Corvera S. Internalization of activated platelet-derived growth factor receptor-phosphatidylinositol-3′ kinase complexes: Potential interactions with the microtubule cytoskeleton. Mol. Cell. Biol. 13 (1993) 6052-6063
139. Kashashian A., and Cooper J.A. Phosphorylation sites at the C-terminus of the platelet-derived growth factor receptor bind phospholipase Cγ1. Mol. Cell. Biol. 4 (1993) 49-57
140. Kashashian A., Kazlauskas A., and Cooper J.A. Phosphorylation sites in the PDGHF receptor with different specificities for binding GAP and PI3 kinase in vivo. EMBO J. 11 (1992) 1373-1382
141. Kavanaugh W.M., Klippel A., Escobedo J.A., and Williams L.T. Modification of the 85-kilodalton subunit of phosphatidylinositol-3 kinase in platelet-derived growth factor-stimulated cells. Mol. Cell. Biol. 12 8 (1992) 3415-3424
142. Kavanaugh W.M., Turck C.W., Klippel A., and Williams L.T. Tyrosine 508 of the 85-kDa subunit of phosphatidylinositol 3-kinase is phosphorylated by the platelet-derived growth factor receptor. Biochemistry 33 (1994) 11045-11050
143. (In press). Kavanaugh W.M., Turck C.W., and Williams L.T. PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science (1995)
144. Kavanaugh W.M., and Williams L.T. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science (1994) 1-3
145. (In Press). Kavanough W.M., Pot D.A., Chin S.M., Deuter-Reinhard M., Jefferson A.B., Norris F.A., Masiarz F.R., Cousens L.S., Majerus P.W., and Williams L.T. Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with SHC and GRB2. Current Biology (1996)
146. Keating M., and William L. Autocrine stimulation of intracellular PDGF receptors in v-sis transformed cells. Science 239 (1988) 914-916
147. Kiefer M.C., Baird A., Nguyen T., George-Nascimento C., Mason O.B., Boley L.J., Valenzuela P., and Barr P.J. Molecular cloning of a human basic fibroblast growth factor receptor cDNA and expression of a biologically active extracellular domain in a baculovirus system. Growth Factors 5 (1991) 115-127
148. Kikuchi A., and Williams L.T. Post-translational Modification of ras p21 is important for Raf-1 Activation. J. Biol. Chem. 269 (1994) 20054-20059
149. Klagsbrun M., and Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 67 (1991) 229-231
150. Klagsbrun M., and D'Amore P.A. Regulators of angiogenesis. Ann. Rev. Physiol. 53 (1991) 217-239
151. Klagsbrun M., and Edelman E.R. Biological and biochemical properties of fibroblast growth factors-implications for the pathogenesis of atherosclerosis. Arteriosclerosis 9 (1989) 269-278
152. Klambt C., Glazer L., and Shilo B.-Z. breathless, a Drosophila FGF receptor homolog, is essential for migration of tracheal and specific midline glial cells. Genes & Development 6 (1992) 1668-1678
153. Klippel A., Escobedo J.A., Hu Q., and Williams L.T. A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo. Mol. Cell. Biol. 13 9 (1993) 5560-5566
154. (In press). Klippel A., Reinhard C., and Williams L.T. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. MCB (1996)
155. Kodaki T., Woscholski R., Hallberg B., Rodriguez-Viciana P., Downward J., and Parker P.J. The activation of phosphatidylinositol 3-kinase by Ras. Curr. Biol. 4 (1994) 798-806
156. Kolch W., Heidecker G., Kochs G., Hummel R., Vahidl H., Mischak H., Finkenzellers G., Marme D., and Rapp U.R. Protein kinase Cα activates RAF-1 by direct phosphorylation. Nature 364 (1993) 249-252
157. Kolls J., Peppel K., Silva M., and Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91 (1994) 215-219
158. Kornfeld K., Horn D.B., and Horvitz H.R. The ksr-1 gene encodes a novel protein kinase involved in ras-mediated signaling in C. elegans. Cell 83 (1995) 903-919
159. Kovalenko M., Gazit A., Bohmer A., Rorsman C., Ronnstrand L., Heldin C.H., Waltenberger J., Bohmer F.D., and Levitzki A. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Research 54 (1994) 6106-6114
160. Kreitman R.J., and Pastan I. Recombinant toxins. (Review). Adv. Pharmacol. 28 (1994) 193-219
161. Kundra V., Escobedo J.A., Kazlauskas A., Kim H.K., Rhee S.G., Williams L.T., and Zetter B. Regulation of chemotaxis by the platelet-derived growth factor receptor β. Nature 367 (1994) 474-476
162. Kurebayashi J., McLeskey S.W., Johnson M.D., Lippman M.E., Dickson R.B., and Kern F.G. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Research 53 (1993) 2178-2187
163. LaBonne C., and Whitman M. Mesoderm induction by activin requires FGF-mediated intracellular signals. Development 120 (1994) 436-472
164. Lange-Carter C.A., and Johnson G.L. Ras-dependent growth factor regulation o MEK kinase in PC12 cells. Science 265 (1994) 1458-1461
165. Lange-Carter C.A., Pleiman C.M., Gardner A.M., Blumer K.J., and Johnson G.L. A Divergence in the MAP Kinase Regulatory Network Defined by MEK Kinase and Raf. Science 260 (1993) 315-319
166. Lappi D.A., Ying W., Barthelemy I., Martineau D., Prieto I., Benatti L., Soria M., and Baird A. Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein. J. Biol. Chem. 269 (1994) 12552-12558
167. Laufer E., Nelson C.E., Johnson R.I., Morgan B.A., and Tabin C. Sonic hedgehog and FGF-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud. Cell 79 (1994) 993-1003
168. Leal F., Williams L.T., and Robbins K.C. Science 230 (1985) 327
169. Lee P.L., Johnson D.E., Cousens L.S., Fried V.A., and Williams L.T. A receptor for basic fibroblast growth factor: Purification and cDNA cloning. Science 245 (1989) 57-60
170. Leevers S.J., Paterson H.F., and Marshall C.J. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369 (1994) 411-414
171. Lehtola L., Partanen J., Sistonene L., Korhonen J., Warri A., Harkonon P., Clarke R., and Alitalo K. Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells. Int. J. Cancer 50 (1992) 598-603
172. Lemmon M.A., and Schlessinger J. Regulation of signal transduction and signal diversity by receptor oligomerization. Tibs 19 (1994) 458-462
173. Leveen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., and Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes and Development 8 (1994) 1875-1887
174. Levitzki A., and Gazit A. Tyrosine kinase inhibition: An approach to drug development. Science 267 (1995) 1782-1788
175. Li L., Zhou J., James G., Heller-Harrison R., Czech M.P., and Olson E.N. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71 (1992) 1181-1194
176. Li S., Janosch P., Tanji M., Rosenfeld G.C., Waymire J.C., Mischak H., Kolch W., and Sedivy J.M. Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins. EMBO 14 4 (1995) 685-696
177. Li W., Nishimura R., Kashishian A., Batzer A.G., Kim W.J.J., Cooper J.A., and Schlessinger J. A new function of a phosphotyrosine phosphatase: Linking GRB2-Sos to a receptor tyrosine kinase. Mol. Cell. Biol. 14 (1994) 509-517
178. Li Y., Basilico C., and Mansukhani A. Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors. Mol. and Cell. Biol. 14 11 (1994) 7660-7669
179. 2 is phosphorylated and activated by MAP kinase. Cell 72 (1993) 269-278
180. Lindner V., Lappi D.A., Baird A., Majack R.A., and Reidy M.A. Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res. 68 (1991) 106-113
181. Lindner V., and Reidy M.A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 88 (1991) 3739-3743
182. Lowenstein E.J., Daly R.J., Batzer A.G., Li W., Margolis B., Lammers R., Ullrich A., Skolnik E.y., Bar S.D., and Schlessinger J. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70 (1992) 431-442
183. MacNicol A.M., Muslin A.J., and Williams L.T. Raf-1 kinase is essential for early xenopus development and mediates the induction of mesoderm by FGF. Cell 73 (1993) 571-583
184. Mansukhani A., Dell'Era P., Moscatelli D., Kornbluth S., Hanafusa H., and Basilico C. Characterization of the murine BEK fibroblast growth factor (FGF) receptor: Activation by three members of the FGF family and requirement for heparin. Proc. Natl. Acad. Sci. USA 89 (1992) 3305-3309
185. Marshall C.J. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80 (1995) 179-185
186. Martin G.A., Viskochil D., Bollag G., McCabe C., Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R.M., Innis M.A., and McCormick F. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63 (1990) 843-849
187. Martin G.A., Yatani A., Clark R., Conroy L., Polakis P., Brown A.M., and McCormick F. GAP domains responsible for ras p21-dependent inhibition of muscarinic atrial K+ channel currents. Science 255 (1992) 192-194
188. Martin G.R. Why thumbs are up. Nature 374 (1995) 410-411
189. Matsuda M., Mayer B.J., and Hanafusa H. Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins. Mol. Cell Biol. 11 (1991) 1607-1613
190. Matuoka K., Shibata M., Yamakawa A., and Takenawa T. Cloning of ASH, a ubiquitous protein composed of one Src homology region (SH)2 and two SH3 domains from human and rat cDNA libraries. Proc. Natl. Acad. Sci. USA 89 (1992) 9015-9019
191. McLesky S.W., Ding I.Y., Lippman M.E., and Kern F.G. MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands. Cancer Research 54 (1994) 523-530
192. Mima T., Ueno H., Fischman D.A., L.T. W., and Mikawa T. Fibroblast growth factor receptor is required for in vivo cardiac myocyte proliferation at early embryonic stages of heart development. Proc. Natl. Acad. Sci. USA 92 (1995) 467-471
193. Minden A., Lin A., McMahon M., Lang-Carter C., Derijard B., Davis R.J., Johnson G.L., and Karin M. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266 (1994) 1719-1723
194. Ming X.F., Burgering B.M.T., Wennstrom S., Claesson-Welsh L., Heldin C.H., Bos J.L., Kozma S.C., and Thomas G. Activation of p70/p85 S6 kinase by a pathway independent of p21. Nature 371 (1994) 426
195. Miyamoto M., Naruo K.-I., Seko C., Matsumoto S., Kondo T., and Kurokawa T. Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol. Cell. Biol. 13 7 (1993) 4251-4259
196. Moodie S.A., Willumsen B.M., Weber M.J., and Wolfman A. Complexes of ras:GTP with raf-1 and mitogen-activated protein kinase kinase. Science 260 (1993) 1658-1661
197. Moon R.T., and Christian J.L. Competence modifiers synergize with growth factors during mesoderm induction and patterning in Xenopus. Cell 71 (1992) 709-712
198. Moore J.W., Dionne C., Jayue M., and Swain J.L. The mRNAs encoding acidic FGF, basic FGF and FGF receptor are coordinately downregulated during myogenic differentiation. Development 111 (1991) 741-748
199. Morrison D. 14-3-3: Modulators of signaling proteins. Science 266 (1994) 56-57
200. Morrison D.K., Heidecker G., Rapp U.R., and Copeland T.D. Identification of the Major Phosphorylation Sites of the Raf-1 Kinase. Biol. Chem. 268 (1993) 17309-17316
201. Morrison-Graham K., Schatteman G.C., Bork T., Bowen-Pope D.F., and Weston J.A. A PDGF receptor mutation in the mouse (Patch) perturbs the development of a non-neuronal subset of neural crest-derived cells. Development 115 (1992) 133-142
202. Mudhar H.S., Pollock R.A., Wang C., Stiles C.D., and Richardson W.D. PDGF and its receptors in the developing rodent retina and optic nerve. Development 118 (1993) 539-552
203. Muenke M., Schell U., Hehr A., Robin N.H., Losken Wolfgang H., Schinzel A., Pulleyn L.J., Rutland P., Reardon W., Malcolm S., and Winter R.M. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genetics 8 (1994) 269-274
204. Musacchio A., Gibson T., Rice P., Thompson J., and Saraste M. The PH domain: A common piece in the structural patchwork of signalling proteins. Tibs 18 (1993) 343-348
205. Muslin A.J., Peters K.G., and Williams L.T. Direct activation of phospholipase C- by fibroblast growth factor receptor is not required for mesoderm induction in Xenopus animal caps. Mol. Cell. Biol. 14 (1994) 3006-3012
206. Muslin A.J., and Williams L.T. Well-defined growth factors promote cardiac development in axolotl mesodermal explants. Development 112 (1991) 1095-1101
207. Neel B.G. Structure and function of SH2-domain containing tyrosine phosphatases. Seminars in Cell Biol. 4 (1993) 419-432
208. Nister M., Hammacher A., Mellstrom K., Siegbahn A., Ronnstrand L., Westermark B., and Heldin C.-H. A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets. Cell 52 (1988) 791-799
209. Niswander L., Jeffrey S., Martin G.R., and Tickle C. A positive feedback loop coordinates growth and pattering in the vertebrate limb. Nature 371 (1994) 609-612
210. Niswander L., Tickle C., Vogel A., Booth L., and Martin G.R. FGF-4 replaces the apical ectodermal ridge and directs outgrowth and patterning of the limb. Cell 75 (1993) 579-587
211. Nobes C.D., Hawkins P., Stephens L., and Hall A. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. Cell Science 108 (1995) 225-233
212. Noguchi T., Matozaki T., Horita K., Fujioka Y., and Kasuga M. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated ras activation. Mol. Cell. Biol. 14 (1994) 6674-6682
213. Obermeier A., Bradshaw R.A., Seedorf K., Choidas A., Schlessinger J., and Ullrich A. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC. EMBO J. 13 (1994) 1585-1590
214. Olson E.N. Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154 (1992) 261-272
215. Olwin B.B., Arthur K., Hannon K., Hein P., McFall A., Riley B., Szebenyi G., Zhou Z., Zuber M., Rapraeger A.C., Fallon J.F., and Kukla A.J. Role of FGFs in skeletal muscle and limb development. Mol. Reprod., & Devel. 39 (1994) 90-101
216. Olwin B.B., Hannon K., and Kudla A.J. Are fibroblast growth factors regulators of myogenesis in vivo?. Prog. Growth Fac. Res. 5 (1994) 45-58
217. Ornitz D.M., Herr A.B., Nilsson M., Westman J., Svahn C.-M., and Waksman G. FGF binding and FGF receptor activation by synthetic heparan-derived d- and trisaccharides. Science 268 (1995) 432-436
218. Ornitz D.M., and Leder P. Ligan specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem. 267 (1992) 16305-16311
219. Ornitz D.M., Yayon A., Flanagan J.G., Svahn C.M., Levi E., and Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12 (1992) 240-247
220. Orr-Urtreger A., Bedford M.T., Do M.S., Eisenbach L., and Lonai P. Developmental expression of the α receptor for platelet-derived growth factor, which is deleted in the embryonic lethal Patch mutation. Development 115 (1992) 289-303
221. Orr-Urtreger A., Givol G., Yayon A., Yarden Y., and Lonai P. Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development 113 (1991) 1419-1434
222. Orr-Urtreger A., and Lonai P. Platelet-derived growth factor-A and its receptor are expressed in separate but adjacent cell layers of the mouse embryo. Development 115 (1992) 289-303
223. Otsu M., Hiles I., Gout I., Fry M.j., Ruiz-Larrea F., Panayotou G., Thompson A., Dhand R., Hsuan J., Totty N., Smith S.J., Morgan S.J., Courtneidge S.A., Parker P.J., and Waterfield M.D. Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60 c-src complexes and PI3-kinase. Cell 65 (1991) 91-104
224. Otto D., and Unsicker K. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: Specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells. J. Neuro. Res. 34 (1993) 382-393
225. Otto D., and Unsicker K. FGF-2 in the MPTP model of Parkinson's disease: Effects on astroglial cells. GLIA 11 (1994) 47-56
226. Pascal S.M., Singer A.U., Gish G., Yamazaki T., Shoelson S.E., Pawson T., Kay L.E., and Forman-Kay. Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gl complexed with a high affinity binding peptide. Cell 77 (1994) 461-472
227. Pawson T. Protein modules and signalling networks. Nature 373 (1995) 573-580
228. Pawson T., and Schlessinger J. The Src-homology domains SH2 and SH3 are protein modules that determine the specificity of protein-protein interactions in the transduction of signals from the cell surface to the nucleus. Current Biol. 3 7 (1993) 434-442
229. Peters K., Ornitz D., Werner S., and Williams L. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Developmental Biology 155 (1993) 423-430
230. Peters K., Werner S., Liao X., Wert S., Whitsett J., and Williams L.T. Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung. EMBO 13 (1994) 3296-3301
231. Peters K.G., Escobedo J.A., Fantl W.J., and Williams L.T. Interactions of PDGF and FGF receptors with cytoplasmic signaling molecules. Cold Spring Harbor Symp. Quant. Biol. 57 (1992) 63-66
232. Peters K.G., Werner S., and Williams L.T. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114 (1992) 233-243
233. Peyrat J.-P., Hondermark H., Louchez M.-M., and Boilly B. Demonstration of basic fibroblast growth factor high and low affinity binding sites in human breast cancer cell lines. Cancer Communications 3 (1991) 323-329
234. Ponten F., Ren Z., Nister M., Westermark B., and Ponten J. Epithelial-stromal interactions in basal cell cancer: The PDGF system. J. Inv. Derm. 102 (1994) 304-309
235. Porras A., Muszynski K., Rapp U., and Santos E. Dissociation between activation of Raf-1 kinase and the 42-kDa mitogen-activated protein kinase/90-kDa S6 kinase (MAPK/RSK) cascade in the insulin/Ras pathway of adipocyte differentiation of 3T3 L1 cells. J. Biol. Chem. 269 (1994) 12741-12748
236. Pringle N.P., Mudhar H.S., Collarini E.J., and Richardson W.D. PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development 115 (1992) 535-551
237. Pronk G.J., and Bos J.L. The role of p21ras in receptor tyrosine kinase signalling. Biochimica et Biophysica Acta 1198 (1994) 131-147
238. ras in PC12 cells by distinct, convergent pathways involving tyrosine phosphorylation. Neuron (1991) 937-946
239. Quilliam L.A., Huff S.Y., Rabun K.M., Wei W., Park W., Broek D., and Der C.J. Membrane-targeting potentiates guanine nucleotide exchange factor CDC25 and SOS1 activation of Ras transforming activity. Proc. Natl. Acad. Sci. USA 91 (1994) 8512-8516
240. Rapraeger A.C., Krufka A., and Olwin B.B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252 (1991) 1705-1708
241. Reardon W., Winter R., Rutland P., Pulleyn L.J., Jones B.M., and Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genetics 8 (1994) 98-103
242. Reich-Slotky R., Bonneh-Barkay D., Shaoul E., Bluma B., Svahn C.M., and Ron D. Differential effect of cell-associated heparin sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor. J. Biol. Chem. 269 (1994) 32279-32285
243. Reichman-Fried M., Dickson B., Hafen E., and Shilo B.-Z. Elucidation of the role of breathless, a Drosophila FGF receptor homolog, in tracheal cell migration. Genes & Development 8 (1994) 428-439
244. Reinhard C., Fernandez A., Lamb N.J.C., and Thomas G. Nuclear localization of p85s6k: functional requirements for entry into S phase. EMBO 13 (1994) 1557-1565
245. Ren R., Ye Z.-S., and Baltimore D. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3 binding sites. Genes Dev 8 (1994) 783-795
246. Rickles R.J., Botfield M.C., Weng Z., Taylor J.A., Green O.M., Brugge J.S., and Zoller M.J. Identification of Src, Fyn, Lyn, P13K and Abl SH3 domain ligands using phage display libraries. EMBO 13 23 (1994) 5598-5604
247. Riddihough G. More meanders and sandwiches. Nature 1 11 (1994) 755-757
248. Ridley A.J. Membrane ruffling and signal transduction. BioEssays 16 (1994) 321-327
249. Ridley A.J., Paterson H.F., Johnston C.L., Diekmann D., and Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell (1992) 401-410
250. Risau W., Drexler H., Mironov V., Smits A., Siegbahn A., Funa K., and Heldin C.H. Platelet-derived growth factor is angiogenic in vivo. Growth Factors 7 (1992) 261-266
251. Robbins K.C., Devare S.G., and Aaronson S.A. Proc. Natl. Acad. Sci. USA 78 (1981) 2918
252. Roche S., Koegl M., and Courtneidge S.A. The phosphatidylinositol 3-kinase α is required for DNA synthesis induced by some, but not all, growth factors. Proc. Natl. Acad. Sci. USA 91 (1994) 9185-9189
253. Rodriguez-Viciana P., Warne P.H., Dhand R., Vanhaesebroeck B., Gout I., Fry M.J., Waterfield M.D., and Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370 (1994) 527-532
254. Roghani M., Mansukhani A., Dell'Era P., Bellosta P., Basilico C., Rifkin D.B., and Moscatelli D. Heparin increased the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269 (1994) 3976-3984
255. Ronnstrand L., Mori S., Arridsson A.-K., Eriksson A., Wernstedt C., Hellman U., Claesson-Welsh L., and Heldin C.-H. Identification of two C-terminal autophosphorylation sites in the PDGF β-receptor: Involvement in the interaction with phospholipase C-γ. EMBO 11 11 (1992) 3911-3919
256. Rosen M.K., Yamazaki T., Gish G.D., Kay C.M., Pawson T., and Kay L.E. Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein. Nature 374 (1995) 477-479
257. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362 (1993) 801-809
258. γ1 enhances substrate phosphorylation by increasing the affinity toward the epidermal growth factor receptor. Biol. Chem. 267 14 (1992) 9678-9683
259. Rousseau F., Bonaventure J., Mallet-Legeai L., Pelet A., Rozet J.M., Maroteaux P., Le Merrer M., and Munnich A. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371 (1994) 252-254
260. Rozakis-Adcock M., Fernley R., Wade J., Pawson T., and Bowtell D. The SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSOS1. Nature 363 (1993) 83-85
261. Rozakis-Adcock M., McGlade J., Mbamalu G., Pelicci G., Daly R., Li W., Batzer A., Thomas S., Brugge J., Pelicci P.G., Schlessinger J., and Pawson T. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360 (1992) 689-692
262. Rubin G.M. Signal transduction and the fate of the R7 photoreceptor in Drosophila. Trends Genet. 360 (1991) 689-692
263. Rubin K., Hansson G.K., Ronnstrand L., Claesson-Welsh L., Fellstrom B., Tingstrom A., Larsson E., Klareskog L., Heldin C.H., and Terracio L. Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: Possible implications for development of vascular proliferative lesions. Lancet 1 (1988) 1353-1356
264. Ruiz L.F., Thompson A., Totty N.F., Hsuan J.J., Courtneidge S.A., Parker P.J., and Waterfield. Phosphatidylinositol 3-kinase: Structure and expression of the 110 kd catalytic subunit. Cell 70 (1992) 419-429
265. Ruoslahti E., and Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 64 (1991) 867-869
266. Rutland P., Pulleyn L.J., Reardon W., Baraitser M., Hayward R., Jones B., Malcolm S., Winter R., Oldridge M., Slaney S.F., Poole M.D., and Wilkie A.O.M. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nature Genetics 9 (1995) 173-177
267. Sabe H., Hata A., Okada M., Nakagawa H., and Hanafusa H. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src. Proc. Natl. Acad. Sci. USA 91 (1994) 3984-3988
268. Sanchez I., Hughes R.T., Mayer B.J., Yee K., Woodgett J.R., Avruch J., Kyriakis J.M., and Zon L.I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372 (1994) 794-800
269. ras. GTP complex in Swiss mouse 3T3 cells. Proc. Natl. Acad. Sci. USA 87 (1990) 5993-5997
270. Satoh T., Fantl W.J., Escobedo J.A., Williams L.T., and Kazio Y. Platelet-derived growth factor receptor mediates activation of Ras through different signaling pathways in different cell types. Mol. Cell. Biol. 13 (1993) 3706-3713
271. Schatteman G.C., Morrison-Graham K., Koppen A.V., Weston J.A., and Bowen-Pope D.F. Regulation and role of PDGF receptor α-subunit expression during embryogenesis. Development 115 (1992) 123-131
272. Scheele J.S., Rhee J.M., and Boss G.R. Determination of absolute amounts of GDP and GTP bound to Ras in mammalian cells: Comparison of parental and Ras-overproducing NIH 3T3 fibroblasts. Cell Biol. 92 (1995) 1097-1100
273. Schlessinger J. How receptor tyrosine kinases activate Ras. TIBS (1993) 273-275
274. Schneider M.D., Kirshenbaum L.A., Brand T., and MacLellan W.R. Control of cardiac gene transcription by fibroblast growth factors. Mol. Reprod. Devel. 39 (1994) 112-117
275. Schu P.V., Takegawa K., Fry M.J., Stack J.H., Waterfield M.D., and Emr S.D. Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science 260 (1993) 88-91
276. Schwartz S.M., and Liaw L. Growth control and morphogenesis in the development and pathology of arteries. J. Cardiovasc. Pharm. 21 (1993) S31-S49
277. Seedorf K., Millauer B., Kostka G., Schlessinger J., and Ullrich A. Differential effects of carboxy-terminal sequence deletions on platelet-derived growth factor receptor signaling activities and interactions with cellular substrates. Mol. Cell. Biol. 12 10 (1992) 4347-4356
278. Shiang R., Thompson L.M., Zhu Y.Z., Church D.M., Fielder T.J., Bocian M., Winokur S.T., and Wasmuth J.J. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, Achondroplasia. Cell 78 (1994) 335-342
279. Shinbrot E., Liao X., and Williams L.T. Isolation and characterization of the platelet-derived growth factor beta receptor promoter. Submitted (1995) 1-27
280. Shinbrot E., Peters K.G., and Williams L.T. Expression of the PDGFβ receptor during development of the mouse embryo. Develop. Dynamics 199 (1994) 169-175
281. Shou C., Farnsworth C.L., Neel B.G., and Feig L.A. Molecular cloning of cDNA's encoding a guanine-nucleotide-releasing factor for Ras p21. Nature 358 (1992) 351-354
282. Shuai K., Ziemiecki A., Wilks A.F., Harpur A.G., Sadowski H.B., Gilman M.Z., and Darnell J.E. Polypeptide signalling through tyrosine phosphorylation of Jak and Stat proteins. Nature 366 (1993) 580-583
283. Silvennoinen O., Schindler C., Schlessinger J., and Levy D.E. Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science 261 (1993) 1736-1739
284. Simon M.A., Bowtell D.D., Dodson G.S., Laverty T.R., and Rubin G.M. Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase. Cell 67 (1991) 701-716
285. Simon M.A., Dodson G.S., and Rubin G.M. An SH3-SH2-SH3 protein is required for p21 Ras1 activation and binds to sevenless and sos proteins in vitro. Cell 73 (1993) 169-177
286. ras with phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 88 (1991) 7908-7912
287. Slack J.M.W. Growth factor lends a hand. Nature 374 (1995) 217-218
288. Smith J.C., and Howard J.E. Mesoderm-inducing factors and the control of gastrulation. Development Supplement (1992) 127-136
289. Songyang Z., Shoelson S.E., Chauhuri M., Gish G., Pawson T., Haser W.G., King F., Roberts T., Ratnofsky S., Lechleider R.J., Neel B.G., Birge R.B., Fajardo J.E., Chou M.M., Hanafusa H., Schaffhausen B., and Cantley L.C. SH2 domains recognize specific phosphopeptide sequences. Cell 72 (1993) 767-778
290. Soriano P. Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes and Development 8 (1994) 1888-1896
291. Spivak-Kroizman T., Lemmon M.A., Dikic I., Ladbury J.E., Pinchasi D., Huang J., Jaye M., Crumley G., Schlessinger J., and Lax I. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79 (1994) 1015-1024
292. Stark K.L., McMahon J.A., and McMahon A.P. FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse. Development 113 (1991) 641-651
293. Stephens L., Cooke F.T., Walters R., Jackson T., Volinia S., Gout I., Waterfield M.D., and Hawkins P.T. Characterization of a phosphatidylinositol-specific phosphoinositide 3-kinase from mammalian cells. Current Biology 4 (1994) 203-214
294. Stephens L., Smrcka A., Cooke F.T., Jackson T.R., Sternweis P.C., and Hawkins P.T. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein βγ subunits. Cell 77 (1994) 83-93
295. Stewart M.J., and Thomas G. Mitogenesis and protein synthesis: A role for ribosomal protein S6 phosphorylation. BioEssays 16 11 (1994) 809-815
296. Stokoe D., Macdonald S.G., Cadwallader K., Symons M., and Hancock J.F. Activation of Raf as a result of recruitment to the plasma membrane. Science 264 (1994) 1463-1467
297. Story M.T. Polypeptide modulators of prostatic growth and development. Cancer Surveys 11 (1991) 123-146
298. Strawn L.M., Mann E., Elliger S.S., Chu L.M., Germain L.L., Niederfellner G., Ullrich A., and Shawver L.K. Inhibition of glioma cell growth by a truncated platelet-derived growth factor-β receptor. J. Biol. Chem. 269 (1994) 21215-21222
299. Sugimoto S., Wandless T.J., Shoelson S.E., Neel B.G., and Walsh C.T. Activation of the SH2-containing protein tyrosin phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1. Biol. Chem. 269 18 (1994) 13614-13622
300. Sundaram M., and Han M. The C. elegans ksr-1 gene encodes a novel raf-related kinase involved in ras-mediated signal transduction. Cell 83 (1995) 889-901
301. Talarico D., Ittmann M.M., Bronson R., and Basilico C. A retrovirus carrying the K-fgf oncogene induces diffuse meningeal tumors and soft-tissue fibrosarcomas. Mol. Cell. Biol. 13 (1993) 1998-2010
302. Tanaka A., Miyamoto K., Minamino N., Takeda M., Sato B., Matsuo H., and Matsumoto K. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc. Natl. Acad. Sci. USA 89 (1992) 8928-8932
303. Tanaka S., Morishita T., Hashimoto Y., Hattori S., Nakamura S., Shibuya M., Matuoka K., Takenawa T., Kurata T., Nagashima K., and Matsuda M. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc. Natl. Acad. Sci. USA 91 (1994) 3443-3447
304. Tang T.L., Freeman R.M., O'Reilly A.M., Neel B.G., and Sokol S.Y. The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. Cell 80 (1995) 473-483
305. Tavormina P.L., Shiang R., Thompson L.M., Zhu Y.-Z., Wilkin D.J., Lackman R.S., Wilcox W.R., Rimoin D.L., Cohn D.H., and Wasmuth J.J. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genetics 9 (1995) 321-328
306. Templeton T.J., and Hauschka S.D. FGF-mediated aspects of skeletal muscle growth and differentiation are controlled by a high affinity receptor, FGFR1. Developmental Biology 154 (1992) 169-181
307. Therrien M., Chang H.C., Solomon N.M., Karim F.D., Wassarman D.A., and Rubin G.M. KSR, a novel protein kinase required for ras signal transduction. Cell 83 (1995) 879-886
308. Thompson T.C. Growth factors and oncogenes in prostate cancer. Cancer Cell 2 (1990) 345-354
309. Thybert J., Nilsson J., Ksiazek T., and Sjolund M. Phenotype modulation in primary carcinoma of arterial smooth muscle cells-on the role of platelet-derived growth factor. Differentiation 25 (1983) 156-167
310. 3. J. Biol. Chem. 269 (1994) 32358-32367
311. Ueno H., Colbert H., Escobedo J.A., and Williams L.T. Inhibition of PDGF β-receptor signal transduction by co-expression of a truncated receptor. Science 252 (1991) 844-848
312. Ueno H., Escobedo J.A., and Williams L.T. Dominant-negative mutations of PDGF receptors: Inhibition of receptor function by ligand-dependent formation of heterodimers between PDGF α- and β-receptors. J. Biol. Chem. 268 (1993) 22814-22819
313. Ueno H., Gunn M., Dell K., Tseng Jr. A., and Williams L. A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor. Biol. Chem. 267 3 (1992) 1470-1476
314. Ullrich A., and Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61 (1990) 203-212
315. Valius M., and Kaslauskas A. Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 73 (1993) 321-324
316. Van Aelst L., Barr M., Marcus S., Polverino A., and Wigler M. Complex formation between RAS and RAF and other protein kinases. Proc. Natl. Acad. Sci. USA 90 (1993) 6213-6217
317. van der Geer P., Hunter T., and Lindberg R.A. Receptor tyrosine kinases and their signal transduction pathways. Annual Reviews in Cell Biology 10 (1994) 251-337
318. Vassbotn F.S., Ostman A., Langeland N., Holmsen H., Westermark B., Heldin C.H., and Nister M. Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line. J. Cell. Physiol. 158 (1994) 381-389
319. Vescovi A.L., Reynolds B.A., Fraser D.D., and Weiss S. bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells. Neuron 11 (1993) 951-966
320. Vojtek A.B., Hollenberg S.M., and Cooper J.A. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74 (1993) 205-214
321. Waksman G., Shoelson S.E., Pant N., Cowburn D., and Kuriyan J. Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms. Cell 72 (1993) 779-790
322. Wang C., and Stiles C.D. Platelet-derived growth factor α receptor gene expression: Isolation and characterization of the promoter and upstream regulatory elements. Proc. Natl. Acad. Sci. USA 91 (1994) 7061-7065
323. Warne P.H., Viciana P.R., and Downward J. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364 (1993) 352-355
324. Wartmann M., and Davis R.J. The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex. J. Biol. Chem. 269 (1994) 695-701
325. (In press). Weng Q.P., Klippel A., Kozlowski M., Williams L.T., and Avruch J. Phosphatidylinositol-3 kinase signals activation of P70 S6 kinase in situ through site specific P70 phosphorylations. Proc. Natl. Acad. Sci. (1995)
326. Wennstrom S., Hawkins P., Cooke F., Hara K., Yonezawa K., Kasuga M., Jackson T., Claesson-Welsh L., and Stephens L. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Current Biology 4 (1994) 385-393
327. Wennstrom S., Siegbahn A., Yokote K., Arvidsson A.-K., Heldin C.-K., Mori S., and Claesson-Welsh L. Membrane ruffling and chemotaxis transduced by the PDGF β-receptor require the binding site for phosphatidylinositol 3′ kinase. Oncogene 9 (1994) 651-660
328. Werner S., Smola H., Liao X., Longaker M.T., Krieg T., and Williams L.T. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 266 (1994) 819-822
329. Werner S., Weinberg W., Liao X., Peters K.G., Blessing M., Yuspa S.H., Weiner R.L., and Williams L.T. Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J. 12 (1993) 2635-2643
330. Westermark B., and Heldin C.H. Platelet-derived growth factor in autocrine transformation. Cancer Research 51 (1991) 5087-5092
331. White M.A., Nicolette C., Minden A., Polverttino A., van Aelst L., Karin M., and Wigler M.H. Multiple ras functions can contribute to mammalian cell transformation. Cell 80 (1995) 533-541
332. Whitman M., Kaplan D., Roberts T., and Cantley L. Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Biochem. J. 247 (1987) 165-174
333. ras in Xenopus mesoderm induction. Nature 357 (1992) 252-254
334. Wilcox J.N., Smith K.M., Williams L.T., Schwartz S.M., and Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J. Clin. Invest. 82 (1988) 1134-1143
335. Wilkie A.O.M., Slaney S.F., Oldridge M., Poole M.D., Ashworth G.J., Hockley A.D., Hayward R.D., David D.J., Pulleyn L.J., Rutland P., Malcolm S., Winter R.M., and Reardon W. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genetics 9 (1995) 165-173
336. Williams E.J., Furness J., Walsh F.S., and Doherty P. Characterization of the second messenger pathway underlying neurite outgrowth stimulated by FGF. Development 120 (1994) 1685-1693
337. Williams L.T. Normal Cell Growth and Growth Factor. In: Isselbacher K.J. (Ed). Harrison's Principles of Internal Medicine (1990), McGraw-Hill, New York 60-64
338. v-src are required, but neither alone is sufficient, to activate the Raf-1 kinase. Proc. Natl. Acad. Sci. USA 89 (1992) 2922-2926
339. Yamaguchi T.P., Harpal K., Henkemeyer M., and Rossant J. FGFR1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes & Development 8 (1994) 3032-3044
340. Yamanaka Y., Friess H., Buchler M., Berger H.G., Uchida E., Onda M., Kobrin M.S., and Korc M. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Research 53 (1993) 5289-5296
341. Yan G., Fukabori Y., McBride G., Nikolaropolous S., and McKeehan W.L. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell Biol. 13 (1993) 4513-4522
342. Yan M., and Templeton D.J. Identification of 2 Serine Residues of MEK-1 That Are Differentially Phosphorylated during Activation by raf and MEK Kinase. Biol. Chem. 269 29 (1994) 19067-19073
343. Yang Y., and Niswander L. Interaction between the signaling molecules WNT7a and SHH during vertebrate limb development: Dorsal signals regulate anteroposterior patterning. Cell 80 (1995) 939-947
344. Yarden Y., Escobedo J.A., Kuang W.-J., Yang-Feng T.L., Daniel T.O., Tremble P.M., Chen E.Y., Ando M.E., Harkins R.N., Francke U., Fried V.A., Ullrich A., and Williams L.T. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323 6085 (1986) 226-232
345. Yayon A., Klagsbrun M., Eski J.D., Leder P., and Ornitz D.M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64 (1991) 841-848
346. Yazaki N., Hosoi Y., Kawabata K., Miyake A., Minami M., Satoh M., Ohta M., Kawasaki T., and Itoh N. Differential expression patterns of mRNAs for members of the fibroblast growth factor receptor family, FGFR1, FGFR4 in rat brain. J. Neuroscience Research 37 (1994) 445-452
347. Yeh H.J., Ruit K.G., Wang Y.X., Parks W.C., Snider W.D., and Deuel T.F. PDGF A-chain gene is expressed by mammalian neurons during development and in maturity. Cell 64 (1991) 209-216
348. Yeh H.J., Silos-Santiago I., Wang Y.X., George R.J., Snider W.D., and Deuel T.F. Developmental expression of the platelet-derived growth factor α-receptor gene in mammalian central nervous system. Proc. Natl. Acad. Sci. USA 90 (1993) 1952-1956
349. Ying W., Martineau D., Beitz J., Lappi D.A., and Baird A. Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin. Cancer 74 (1994) 848-853
350. Yu H., Chen J.K., Feng S., Dalgarno D.C., Brauer A.W., and Schreiber S.L. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76 (1994) 933-945
351. ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 364 (1993) 308-313
352. Zhou M.M., Ravichandran K.S., Olenjniczak E.F., Petros A.M.,R.P.,M., Sattler M., Harlan J.E., Wade W.S., Burakoff S.J., and Fesik S.W. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature 378 (1995) 6557